What is ClinOne?
Founded in 2013 and headquartered in Needham, Massachusetts, ClinOne provides a comprehensive software suite designed to optimize clinical trial enrollment, retention, and research site compliance. The company's core value proposition lies in its ability to place essential trial information directly into the hands of researchers and patients, thereby reducing administrative friction and improving overall study outcomes. By digitizing the patient experience and automating site-level tasks, ClinOne addresses the high-stakes requirements of global clinical research, positioning itself as an indispensable partner for organizations navigating the complexities of drug development and medical device testing.
How much funding has ClinOne raised?
ClinOne has raised a total of $5M across 1 funding round:
Series A
$5M
Series A (2023): $5M with participation from First Trust Capital Partners, Boulder Ventures, CU Healthcare Innovation Fund, and Highpoint Ventures
Key Investors in ClinOne
First Trust Capital Partners
First Trust Capital Partners specializes in early and growth stage investments, particularly within the healthcare technology and financial services sectors, emphasizing long-term capital appreciation.
Boulder Ventures
Boulder Ventures is a venture capital firm focused on IT and biotechnology, leveraging a strong track record of successful exits and IPOs to support innovative startups.
CU Healthcare Innovation Fund
Affiliated with the University of Colorado Anschutz Medical Campus, this fund focuses on advancing healthcare innovation by connecting portfolio companies with extensive clinical research networks.
What's next for ClinOne?
With this latest capital injection, ClinOne is well-positioned to accelerate its product development roadmap and expand its footprint within the global clinical research ecosystem. The company is expected to leverage these resources to enhance its platform's interoperability with existing electronic health record systems and further refine its patient-facing mobile interfaces. As the demand for more efficient, transparent, and compliant clinical trials continues to rise, ClinOne's strategic focus on reducing the burden on research sites and improving the participant experience will likely remain a key driver of its long-term growth and market penetration.
See full ClinOne company page